1: Biopharmaceutics & PK, Routes of Administration

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/31

encourage image

There's no tags or description

Looks like no tags are added yet.

32 Terms

1
New cards

PK

what the body does to the drug

2
New cards

What does PK define?

drug exposure

3
New cards

What’s the main focus in PK? What is this often in equilibrium with?

Cp: plasma drug concentration

Csite (often in equilibrium w/)

4
New cards

PD

what the drug does to the body

5
New cards

What does PD define?

drug effects

6
New cards

biopharmaceutics

Study of how a drug’s properties influence the:

  • administration of drug (route, dosage forms)

  • PK behavior of dosage form (rate and extend of drug absorption)


7
New cards

Absorption

drug passing from site of administration to systemic (blood) circulation

8
New cards

Distribution

drug movement from site of absorption to site of action and site of metabolism/excretion

9
New cards

AUC

area under curve
extent of exposure to a drug

10
New cards

Metabolism

Irreversible alteration of drug chemistry

11
New cards

Excretion

passage of drugs/metabolites out of the body

(best described by CL/clearance)

12
New cards

What happens to excretion when a patient has renal failure?

Renal failure = compromised elimination
Drug stays in body longer than necessary

13
New cards

What do the M&E of ADME describe? What does this determine?

Elimination/Clearance; plasma elimination determines dosing frequency

14
New cards

Therapeutic Range/Window; include range boundaries

  • Range of C where a drug is therapeutically beneficial

  • MEC = lower bound

  • MTC = upper bound


15
New cards

How should drugs w/ narrow TRs be dosed? Why?

smaller, more frequent doses (also monitor closely)

More frequency = less fluctuation (less time for concentration to drop, more likely to stay in TR)

16
New cards

how should drugs with slow elimination rates be dosed?

1 large initial dose, followed by small doses

17
New cards

accumulation

The Cmax of a subsequent dose changes compared to the prior dose

18
New cards

Absorption can best be described by

F (bioavailability)

ka (absorption rate constant)

19
New cards

F

bioavailability

(how much is absorbed)

20
New cards

ka

absorption rate constant
(how fast is drug being absorbed)

21
New cards

Distribution can best be described by

Vd (volume of distribution)

22
New cards

Vd

volume of distribution
(how much leaves plasma and distributes into tissues)

23
New cards

Elimination can best be described by

CL (clearance)

t1/2 (half-life)

24
New cards

CL

clearance

(how well can the liver/kidneys remove drug from plasma)

25
New cards

t1/2

half life

(how quickly drug is eliminated)

26
New cards

What are two pros to parenteral route administration?

  1. Avoid GI and first-pass effect

  2. Fast onset of action (reliable response)


27
New cards

What are 3 cons to parenteral route administration?

  1. Needs aseptic technique

  2. Frequent dosing poses a problem

  3. Difficult to correct errors during administration


28
New cards

IV administration

inject directly into veins → no absorption process involved, 100% bioavailability (rapid onset)

29
New cards

IM administration

injection into relaxed muscle (faster than SC; larger volumes can be given)

30
New cards

SC administration

small volume injected into loose connective and adipose tissue (easy self-medication)

31
New cards

What drug administration routes bypass 1st-pass metabolism?

  1. All parenteral routes

  2. Buccal/Sublingual

  3. Transdermal

  4. Pulmonary

  5. Intranasal

  6. Suppository


32
New cards

Bioavailability definition and what does it determine?

Fraction of administered does that reaches systemic circulation unchanged

effective dose